{"parse":{"title":"Atypical hemolytic uremic syndrome","pageid":38187439,"revid":842499914,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"infobox\" style=\"width:22em\"><tbody><tr><th colspan=\"2\" style=\"text-align:center;font-size:125%;font-weight:bold;background:#ccc\">Atypical hemolytic uremic syndrome</th></tr><tr><th scope=\"row\"><a href=\"/wiki/Specialty_(medicine)\" title=\"Specialty (medicine)\">Specialty</a></th><td>\n<a href=\"/wiki/Hematology\" title=\"Hematology\">Hematology</a>&#160;<a href=\"https://www.wikidata.org/wiki/Q17165460?uselang=\u29fclang\u29fd#P1995\" title=\"Edit this on Wikidata\"><img alt=\"Edit this on Wikidata\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/10px-Blue_pencil.svg.png\" width=\"10\" height=\"10\" style=\"vertical-align: text-top\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/15px-Blue_pencil.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/20px-Blue_pencil.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /></a></td></tr></tbody></table>\n<p><b>Atypical hemolytic uremic syndrome</b> (<b>aHUS</b>) is an extremely rare, life-threatening, progressive disease that frequently has a genetic component. In most cases it is caused by chronic, uncontrolled activation of the <a href=\"/wiki/Complement_system\" title=\"Complement system\">complement system</a>,<sup id=\"cite_ref-Loirat2008_1-0\" class=\"reference\"><a href=\"#cite_note-Loirat2008-1\">&#91;1&#93;</a></sup> a branch of the body\u2019s immune system that destroys and removes foreign particles.<sup id=\"cite_ref-Walport2001_2-0\" class=\"reference\"><a href=\"#cite_note-Walport2001-2\">&#91;2&#93;</a></sup> The disease affects both children and adults and is characterized by systemic <a href=\"/wiki/Thrombotic_microangiopathy\" title=\"Thrombotic microangiopathy\">thrombotic microangiopathy</a> (TMA), the formation of blood clots in small blood vessels throughout the body, which can lead to stroke, heart attack, kidney failure, and death.<sup id=\"cite_ref-Loirat2008_1-1\" class=\"reference\"><a href=\"#cite_note-Loirat2008-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Hosler2003_3-0\" class=\"reference\"><a href=\"#cite_note-Hosler2003-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-Noris2010_4-0\" class=\"reference\"><a href=\"#cite_note-Noris2010-4\">&#91;4&#93;</a></sup> The complement system activation may be due to mutations in the complement regulatory proteins (factor H, factor I, or membrane cofactor protein),<sup id=\"cite_ref-Noris2010_4-1\" class=\"reference\"><a href=\"#cite_note-Noris2010-4\">&#91;4&#93;</a></sup><sup id=\"cite_ref-Caprioli2006_5-0\" class=\"reference\"><a href=\"#cite_note-Caprioli2006-5\">&#91;5&#93;</a></sup> or is occasionally due to acquired neutralizing autoantibody inhibitors of these complement system components, for example anti\u2013factor H antibodies.<sup id=\"cite_ref-Hoffman_2012_6_6-0\" class=\"reference\"><a href=\"#cite_note-Hoffman_2012_6-6\">&#91;6&#93;</a></sup><sup class=\"reference\" style=\"white-space:nowrap;\">:<span>1933</span></sup> Despite the use of supportive care, historically an estimated 33\u201340% of patients died or developed end-stage renal disease (ESRD) with the first clinical bout of aHUS. Including subsequent relapses, a total of approximately two-thirds (65%) of patients died, required dialysis, or had permanent renal damage within the first year after diagnosis despite plasma exchange or plasma infusion (PE/PI).<sup id=\"cite_ref-Caprioli2006_5-1\" class=\"reference\"><a href=\"#cite_note-Caprioli2006-5\">&#91;5&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Signs_and_symptoms\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Signs and symptoms</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-2\"><a href=\"#Comorbidities\"><span class=\"tocnumber\">1.1</span> <span class=\"toctext\">Comorbidities</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Mechanisms\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Mechanisms</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Diagnosis\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Diagnosis</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Treatment\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Treatment</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-6\"><a href=\"#Plasma_exchange/infusion\"><span class=\"tocnumber\">4.1</span> <span class=\"toctext\">Plasma exchange/infusion</span></a></li>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#Eculizumab\"><span class=\"tocnumber\">4.2</span> <span class=\"toctext\">Eculizumab</span></a></li>\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#Dialysis\"><span class=\"tocnumber\">4.3</span> <span class=\"toctext\">Dialysis</span></a></li>\n<li class=\"toclevel-2 tocsection-9\"><a href=\"#Kidney_transplantation\"><span class=\"tocnumber\">4.4</span> <span class=\"toctext\">Kidney transplantation</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-10\"><a href=\"#Prognosis\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Prognosis</span></a></li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#Epidemiology\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">Epidemiology</span></a></li>\n<li class=\"toclevel-1 tocsection-12\"><a href=\"#Society_and_culture\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">Society and culture</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-13\"><a href=\"#Naming\"><span class=\"tocnumber\">7.1</span> <span class=\"toctext\">Naming</span></a></li>\n<li class=\"toclevel-2 tocsection-14\"><a href=\"#Research_directions\"><span class=\"tocnumber\">7.2</span> <span class=\"toctext\">Research directions</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-15\"><a href=\"#References\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-16\"><a href=\"#External_links\"><span class=\"tocnumber\">9</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Signs_and_symptoms\">Signs and symptoms</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Atypical_hemolytic_uremic_syndrome&amp;action=edit&amp;section=1\" title=\"Edit section: Signs and symptoms\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Clinical signs and symptoms of complement-mediated TMA can include abdominal pain,<sup id=\"cite_ref-Ohanian2011_7-0\" class=\"reference\"><a href=\"#cite_note-Ohanian2011-7\">&#91;7&#93;</a></sup> confusion,<sup id=\"cite_ref-Ohanian2011_7-1\" class=\"reference\"><a href=\"#cite_note-Ohanian2011-7\">&#91;7&#93;</a></sup> fatigue,<sup id=\"cite_ref-Noris2010_4-2\" class=\"reference\"><a href=\"#cite_note-Noris2010-4\">&#91;4&#93;</a></sup> edema (swelling),<sup id=\"cite_ref-Stahl2008_8-0\" class=\"reference\"><a href=\"#cite_note-Stahl2008-8\">&#91;8&#93;</a></sup> nausea/vomiting<sup id=\"cite_ref-Dragon2010_9-0\" class=\"reference\"><a href=\"#cite_note-Dragon2010-9\">&#91;9&#93;</a></sup> and diarrhea.<sup id=\"cite_ref-Zuber2011_10-0\" class=\"reference\"><a href=\"#cite_note-Zuber2011-10\">&#91;10&#93;</a></sup>  aHUS often presents with malaise and fatigue, as well as microangiopathic anemia.<sup id=\"cite_ref-Hoffman_2012_6_6-1\" class=\"reference\"><a href=\"#cite_note-Hoffman_2012_6-6\">&#91;6&#93;</a></sup><sup class=\"reference\" style=\"white-space:nowrap;\">:<span>1931</span></sup> However, severe abdominal pain and bloody diarrhea are unusual.<sup id=\"cite_ref-Hoffman_2012_6_6-2\" class=\"reference\"><a href=\"#cite_note-Hoffman_2012_6-6\">&#91;6&#93;</a></sup><sup class=\"reference\" style=\"white-space:nowrap;\">:<span>1931</span></sup>  Laboratory tests may also reveal low levels of platelets (cells in the blood that aid in clotting),<sup id=\"cite_ref-Loirat2008_1-2\" class=\"reference\"><a href=\"#cite_note-Loirat2008-1\">&#91;1&#93;</a></sup> elevated lactate dehydrogenase (LDH, a chemical released from damaged cells, and which is therefore a marker of cellular damage),<sup id=\"cite_ref-Caprioli2006_5-2\" class=\"reference\"><a href=\"#cite_note-Caprioli2006-5\">&#91;5&#93;</a></sup> decreased haptoglobin (indicative of the breakdown of red blood cells),<sup id=\"cite_ref-Caprioli2006_5-3\" class=\"reference\"><a href=\"#cite_note-Caprioli2006-5\">&#91;5&#93;</a></sup> anemia (low red blood cell count)/schistocytes (damaged red blood cells),<sup id=\"cite_ref-Loirat2008_1-3\" class=\"reference\"><a href=\"#cite_note-Loirat2008-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Caprioli2006_5-4\" class=\"reference\"><a href=\"#cite_note-Caprioli2006-5\">&#91;5&#93;</a></sup> elevated creatinine (indicative of kidney dysfunction),<sup id=\"cite_ref-Ariceta2009_11-0\" class=\"reference\"><a href=\"#cite_note-Ariceta2009-11\">&#91;11&#93;</a></sup> and proteinuria (indicative of kidney injury).<sup id=\"cite_ref-Sellier2007_12-0\" class=\"reference\"><a href=\"#cite_note-Sellier2007-12\">&#91;12&#93;</a></sup> Patients with aHUS often present with an abrupt onset of systemic signs and symptoms such as acute kidney failure,<sup id=\"cite_ref-Loirat2008_1-4\" class=\"reference\"><a href=\"#cite_note-Loirat2008-1\">&#91;1&#93;</a></sup> hypertension (high blood pressure),<sup id=\"cite_ref-Noris2010_4-3\" class=\"reference\"><a href=\"#cite_note-Noris2010-4\">&#91;4&#93;</a></sup> myocardial infarction (heart attack),<sup id=\"cite_ref-Sallee2010_13-0\" class=\"reference\"><a href=\"#cite_note-Sallee2010-13\">&#91;13&#93;</a></sup> stroke,<sup id=\"cite_ref-Ohanian2011_7-2\" class=\"reference\"><a href=\"#cite_note-Ohanian2011-7\">&#91;7&#93;</a></sup> lung complications,<sup id=\"cite_ref-Sallee2010_13-1\" class=\"reference\"><a href=\"#cite_note-Sallee2010-13\">&#91;13&#93;</a></sup> pancreatitis (inflammation of the pancreas),<sup id=\"cite_ref-Dragon2010_9-1\" class=\"reference\"><a href=\"#cite_note-Dragon2010-9\">&#91;9&#93;</a></sup> liver necrosis (death of liver cells or tissue),<sup id=\"cite_ref-Noris2010_4-4\" class=\"reference\"><a href=\"#cite_note-Noris2010-4\">&#91;4&#93;</a></sup> encephalopathy (brain dysfunction),<sup id=\"cite_ref-Noris2010_4-5\" class=\"reference\"><a href=\"#cite_note-Noris2010-4\">&#91;4&#93;</a></sup> seizure,<sup id=\"cite_ref-Neuhaus1997_14-0\" class=\"reference\"><a href=\"#cite_note-Neuhaus1997-14\">&#91;14&#93;</a></sup> or coma.<sup id=\"cite_ref-Noris2005_15-0\" class=\"reference\"><a href=\"#cite_note-Noris2005-15\">&#91;15&#93;</a></sup> Failure of neurologic, cardiac, kidney, and gastrointestinal (GI) organs, as well as death, can occur unpredictably at any time, either very quickly or following prolonged symptomatic or asymptomatic disease progression.<sup id=\"cite_ref-Loirat2008_1-5\" class=\"reference\"><a href=\"#cite_note-Loirat2008-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Sellier2007_12-1\" class=\"reference\"><a href=\"#cite_note-Sellier2007-12\">&#91;12&#93;</a></sup><sup id=\"cite_ref-Noris2009_16-0\" class=\"reference\"><a href=\"#cite_note-Noris2009-16\">&#91;16&#93;</a></sup><sup id=\"cite_ref-Benz2010_17-0\" class=\"reference\"><a href=\"#cite_note-Benz2010-17\">&#91;17&#93;</a></sup><sup id=\"cite_ref-Mache2009_18-0\" class=\"reference\"><a href=\"#cite_note-Mache2009-18\">&#91;18&#93;</a></sup> For example, approximately 1 in 6 patients with aHUS initially will present with proteinuria or hematuria without acute kidney failure.<sup id=\"cite_ref-Sellier2007_12-2\" class=\"reference\"><a href=\"#cite_note-Sellier2007-12\">&#91;12&#93;</a></sup> Patients who survive the presenting signs and symptoms endure a chronic thrombotic and inflammatory state, which puts many of them at lifelong elevated risk of sudden blood clotting, kidney failure, other severe complications and premature death.<sup id=\"cite_ref-Stahl2008_8-1\" class=\"reference\"><a href=\"#cite_note-Stahl2008-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-Zipfel2010_19-0\" class=\"reference\"><a href=\"#cite_note-Zipfel2010-19\">&#91;19&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Comorbidities\">Comorbidities</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Atypical_hemolytic_uremic_syndrome&amp;action=edit&amp;section=2\" title=\"Edit section: Comorbidities\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Although many patients experience aHUS as a single disease, comorbidities are common. In one study, 25% (47/191) of patients with no known family history of aHUS were found to have a coexisting disease or condition. Comorbidities in this study included malignant hypertension (30%), TMA with a history of transplant (23%), TMA associated with pregnancy (21%), <a href=\"/wiki/Glomerulopathy\" title=\"Glomerulopathy\">glomerulopathy</a> (17%), systemic disease such as <a href=\"/wiki/Systemic_lupus_erythematosus\" title=\"Systemic lupus erythematosus\">systemic lupus erythematosus (SLE)</a> or <a href=\"/wiki/Systemic_scleroderma\" title=\"Systemic scleroderma\">progressive systemic sclerosis (PSS)</a> (6%), and malignancy (1%).<sup id=\"cite_ref-Noris2010_4-6\" class=\"reference\"><a href=\"#cite_note-Noris2010-4\">&#91;4&#93;</a></sup> The presence of mutations in complement regulatory proteins, or of disease-associated variations in the genes encoding these proteins (i.e., in most patients with comorbid conditions as well as in patients with aHUS as a single disease), suggests that deviations from the normal genetic coding of these factors could result in a genetic predisposition to TMA. Individuals so predisposed could have aHUS episodes precipitated by one of the known disease triggers (e.g., infection, pregnancy, surgery, trauma) as well as by other systemic diseases (e.g., malignant hypertension, SLE, cancer).\n</p>\n<h2><span class=\"mw-headline\" id=\"Mechanisms\">Mechanisms</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Atypical_hemolytic_uremic_syndrome&amp;action=edit&amp;section=3\" title=\"Edit section: Mechanisms\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>In healthy individuals, complement is used to attack foreign substances, and the complement system is highly regulated to prevent it from damaging healthy tissues and organs.<sup id=\"cite_ref-Loirat2008_1-6\" class=\"reference\"><a href=\"#cite_note-Loirat2008-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Noris2009_16-1\" class=\"reference\"><a href=\"#cite_note-Noris2009-16\">&#91;16&#93;</a></sup> However, in most patients with aHUS, it has been demonstrated that chronic, uncontrolled, and excessive activation of complement can result from production of anti-factor H autoantibodies or from genetic mutations in any of several complement regulatory proteins (e.g., factor H, factor HR1 or HR3, membrane cofactor protein, factor I, factor B, complement C3, and thrombomodulin).<sup id=\"cite_ref-Noris2009_16-2\" class=\"reference\"><a href=\"#cite_note-Noris2009-16\">&#91;16&#93;</a></sup> This results in platelet activation, damage to <a href=\"/wiki/Endothelial_cells\" class=\"mw-redirect\" title=\"Endothelial cells\">endothelial cells</a> (cells that line the blood vessels), and white blood cell activation, leading to systemic TMA, which manifests as decreased platelet count, <a href=\"/wiki/Hemolysis\" title=\"Hemolysis\">hemolysis</a> (breakdown of red blood cells), damage to multiple organs, and often, death.<sup id=\"cite_ref-Sellier2007_12-3\" class=\"reference\"><a href=\"#cite_note-Sellier2007-12\">&#91;12&#93;</a></sup><sup id=\"cite_ref-Benz2010_17-1\" class=\"reference\"><a href=\"#cite_note-Benz2010-17\">&#91;17&#93;</a></sup><sup id=\"cite_ref-Tsai2010_20-0\" class=\"reference\"><a href=\"#cite_note-Tsai2010-20\">&#91;20&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Diagnosis\">Diagnosis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Atypical_hemolytic_uremic_syndrome&amp;action=edit&amp;section=4\" title=\"Edit section: Diagnosis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>aHUS is not the only condition that causes systemic TMA, a fact that makes differential diagnosis essential. Historically, the clinical diagnosis of TMA-causing diseases was grouped into a broad category that (in addition to aHUS) included <a href=\"/wiki/Thrombotic_thrombocytopenic_purpura\" title=\"Thrombotic thrombocytopenic purpura\">thrombotic thrombocytopenic purpura</a> (TTP) and Shiga-toxin-producing Escherichia coli hemolytic uremic syndrome (<a href=\"/wiki/STEC-HUS\" class=\"mw-redirect\" title=\"STEC-HUS\">STEC-HUS</a>).<sup id=\"cite_ref-Benz2010_17-2\" class=\"reference\"><a href=\"#cite_note-Benz2010-17\">&#91;17&#93;</a></sup><sup id=\"cite_ref-Zipfel2010_19-1\" class=\"reference\"><a href=\"#cite_note-Zipfel2010-19\">&#91;19&#93;</a></sup> However, it is now understood that although aHUS, STEC-HUS, and TTP have similar clinical presentations, they have distinct causes and specific tests can be conducted to differentiate these diseases. In addition, there are other conditions that can cause TMA as a secondary manifestation; these entities include systemic lupus erythematosus (SLE), malignant hypertension, progressive systemic sclerosis (PSS, also known as scleroderma), the pregnancy-associated HELLP (hemolysis, liver dysfunction, and low platelets) syndrome, and toxic drug reaction (e.g., to cocaine, cyclosporine, or tacrolimus).  Nevertheless, aHUS should be suspected in patients presenting with systemic TMA, and appropriate diagnostic work-up should be undertaken.\n</p><p>The neurological and kidney-related signs and symptoms of aHUS overlap with those of TTP.<sup id=\"cite_ref-Ariceta2009_11-1\" class=\"reference\"><a href=\"#cite_note-Ariceta2009-11\">&#91;11&#93;</a></sup><sup id=\"cite_ref-George2010_21-0\" class=\"reference\"><a href=\"#cite_note-George2010-21\">&#91;21&#93;</a></sup> However, unlike aHUS, TTP is primarily an autoimmune disorder in which the presence of an inhibitory autoantibody results in severe deficiency of <a href=\"/wiki/ADAMTS13\" title=\"ADAMTS13\">ADAMTS13</a>, an enzyme that cleaves von Willebrand factor (vWf), a large protein involved in blood clotting, into smaller pieces.<sup id=\"cite_ref-Tsai2010_20-1\" class=\"reference\"><a href=\"#cite_note-Tsai2010-20\">&#91;20&#93;</a></sup> (TTP also can be a genetic disorder characterized by mutations in the ADAMTS13 gene leading to severe ADAMTS13 deficiency. This congenital cause of ADAMTS13 deficiency is called Upshaw-Sch\u00fclman syndrome.<sup id=\"cite_ref-Moake2004_22-0\" class=\"reference\"><a href=\"#cite_note-Moake2004-22\">&#91;22&#93;</a></sup>) A lab test showing ADAMTS13 activity levels of \u22645% is indicative of TTP.<sup id=\"cite_ref-Tsai2010_20-2\" class=\"reference\"><a href=\"#cite_note-Tsai2010-20\">&#91;20&#93;</a></sup>\n</p><p>Similarly, the gastrointestinal (GI) signs and symptoms of aHUS overlap with those of STEC-HUS.<sup id=\"cite_ref-Zuber2011_10-1\" class=\"reference\"><a href=\"#cite_note-Zuber2011-10\">&#91;10&#93;</a></sup><sup id=\"cite_ref-Fang2008_23-0\" class=\"reference\"><a href=\"#cite_note-Fang2008-23\">&#91;23&#93;</a></sup><sup id=\"cite_ref-Bitzan2010_24-0\" class=\"reference\"><a href=\"#cite_note-Bitzan2010-24\">&#91;24&#93;</a></sup> Stool samples from patients with diarrhea or other GI symptoms should be tested for STEC and the presence of Shiga-toxin. However, a positive identification of Shiga-toxin, which is required to diagnose STEC-HUS, does not rule out aHUS. Nevertheless, in the appropriate clinical setting, a positive identification of Shiga-toxin makes aHUS very unlikely.<sup id=\"cite_ref-Ariceta2009_11-2\" class=\"reference\"><a href=\"#cite_note-Ariceta2009-11\">&#91;11&#93;</a></sup><sup id=\"cite_ref-Bitzan2010_24-1\" class=\"reference\"><a href=\"#cite_note-Bitzan2010-24\">&#91;24&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Treatment\">Treatment</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Atypical_hemolytic_uremic_syndrome&amp;action=edit&amp;section=5\" title=\"Edit section: Treatment\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Before the introduction of <a href=\"/wiki/Eculizumab\" title=\"Eculizumab\">eculizumab</a> (<a href=\"/wiki/International_Nonproprietary_Name\" class=\"mw-redirect\" title=\"International Nonproprietary Name\">INN</a> and <a href=\"/wiki/USAN\" class=\"mw-redirect\" title=\"USAN\">USAN</a>, trade name Soliris), a <a href=\"/wiki/Monoclonal_antibody\" title=\"Monoclonal antibody\">monoclonal antibody</a> that is a first-in-class terminal <a href=\"/wiki/Complement_system\" title=\"Complement system\">complement</a> inhibitor, management options for patients with aHUS were extremely limited. Guidelines issued by the European Paediatric Study Group for HUS recommend rapid administration of <a href=\"/wiki/Plasma_exchange\" class=\"mw-redirect\" title=\"Plasma exchange\">plasma exchange</a> or <a href=\"/w/index.php?title=Plasma_infusion&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Plasma infusion (page does not exist)\">plasma infusion</a> (PE/PI), intensively administered daily for 5 days and then with reducing frequency.<sup id=\"cite_ref-George2010_21-1\" class=\"reference\"><a href=\"#cite_note-George2010-21\">&#91;21&#93;</a></sup> However, the American Society for Apheresis offers a \"weak\" recommendation for plasma exchange to treat aHUS, due to the \"low\" or \"very low\" quality of evidence supporting its use. Although some patients experienced improvements in red blood cell and platelet counts, plasma therapies generally did not result in full remission.<sup id=\"cite_ref-Szczepiorkowski2010_25-0\" class=\"reference\"><a href=\"#cite_note-Szczepiorkowski2010-25\">&#91;25&#93;</a></sup>\n</p>\n<h3><span id=\"Plasma_exchange.2Finfusion\"></span><span class=\"mw-headline\" id=\"Plasma_exchange/infusion\">Plasma exchange/infusion</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Atypical_hemolytic_uremic_syndrome&amp;action=edit&amp;section=6\" title=\"Edit section: Plasma exchange/infusion\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Although plasma exchange/infusion (PE/PI) is frequently used, there are no controlled trials of its safety or efficacy in aHUS. Even though PE/PI often partially controls some of the hematological manifestations of aHUS in some patients, its effectiveness has not been demonstrated in terms of inducing total disease remission.  PE/PI is associated with significant safety risks, including risk of infection, allergic reactions, thrombosis, loss of vascular access, and poor quality of life.<sup id=\"cite_ref-George2010_21-2\" class=\"reference\"><a href=\"#cite_note-George2010-21\">&#91;21&#93;</a></sup><sup id=\"cite_ref-Michon2007_26-0\" class=\"reference\"><a href=\"#cite_note-Michon2007-26\">&#91;26&#93;</a></sup> Importantly, terminal complement activation has been shown to be chronically present on the surface of platelets in patients with aHUS who appear to be clinically well while receiving chronic PE/PI.<sup id=\"cite_ref-Stahl2008_8-2\" class=\"reference\"><a href=\"#cite_note-Stahl2008-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-Licht2009_27-0\" class=\"reference\"><a href=\"#cite_note-Licht2009-27\">&#91;27&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Eculizumab\">Eculizumab</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Atypical_hemolytic_uremic_syndrome&amp;action=edit&amp;section=7\" title=\"Edit section: Eculizumab\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><a href=\"/wiki/Eculizumab\" title=\"Eculizumab\">Eculizumab</a> appears to be useful for atypical hemolytic uremic syndrome (aHUS).<sup id=\"cite_ref-Drug2013_28-0\" class=\"reference\"><a href=\"#cite_note-Drug2013-28\">&#91;28&#93;</a></sup> In September 2011 the <a href=\"/wiki/U.S._Food_and_Drug_Administration\" class=\"mw-redirect\" title=\"U.S. Food and Drug Administration\">U.S. Food and Drug Administration</a> (FDA) approved it as an <a href=\"/wiki/Orphan_drug\" title=\"Orphan drug\">orphan drug</a> to treat people with aHUS.<sup id=\"cite_ref-FDA_2011_29-0\" class=\"reference\"><a href=\"#cite_note-FDA_2011-29\">&#91;29&#93;</a></sup> This approval was based on two small prospective trials of 17 people and 20 people.<sup id=\"cite_ref-Drug2013_28-1\" class=\"reference\"><a href=\"#cite_note-Drug2013-28\">&#91;28&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Dialysis\">Dialysis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Atypical_hemolytic_uremic_syndrome&amp;action=edit&amp;section=8\" title=\"Edit section: Dialysis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Patients with aHUS who have ESRD are generally consigned to lifelong dialysis, which carries a 5-year survival rate of 34\u201338%,<sup id=\"cite_ref-Collins2010_30-0\" class=\"reference\"><a href=\"#cite_note-Collins2010-30\">&#91;30&#93;</a></sup><sup id=\"cite_ref-European2011_31-0\" class=\"reference\"><a href=\"#cite_note-European2011-31\">&#91;31&#93;</a></sup> with infections accounting for 14% of deaths.<sup id=\"cite_ref-Klevens2008_32-0\" class=\"reference\"><a href=\"#cite_note-Klevens2008-32\">&#91;32&#93;</a></sup> These patients also remain at ongoing risk of non-kidney systemic complications of the disease.\n</p>\n<h3><span class=\"mw-headline\" id=\"Kidney_transplantation\">Kidney transplantation</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Atypical_hemolytic_uremic_syndrome&amp;action=edit&amp;section=9\" title=\"Edit section: Kidney transplantation\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Despite its history of use in patients with aHUS, kidney transplantation does not address the continued and uncontrolled complement activation that leads to progressive, systemic TMA. As many as 90% of patients with aHUS experience TMA in the transplanted organ, leading to transplant failure.<sup id=\"cite_ref-Zuber2011_10-2\" class=\"reference\"><a href=\"#cite_note-Zuber2011-10\">&#91;10&#93;</a></sup><sup id=\"cite_ref-Kavanagh2010_33-0\" class=\"reference\"><a href=\"#cite_note-Kavanagh2010-33\">&#91;33&#93;</a></sup> Patients who have undergone kidney transplantation are still at continued risk of neurological, gastrointestinal, and cardiovascular complications and, importantly, premature mortality. Following kidney transplantation, the ongoing, uncontrolled, chronic complement activation associated with aHUS causes graft loss in 66% of children and 55% of adults, as well as continued inflammatory and TMA insult to other organs.<sup id=\"cite_ref-Loirat2008_1-7\" class=\"reference\"><a href=\"#cite_note-Loirat2008-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Noris2010_4-7\" class=\"reference\"><a href=\"#cite_note-Noris2010-4\">&#91;4&#93;</a></sup> Combined liver-kidney transplantation is only available to very few patients, due to the limited supply of solid organs. In addition, there is a substantial near-term risk of mortality, which many physicians and patients consider excessive.<sup id=\"cite_ref-Loirat2008_1-8\" class=\"reference\"><a href=\"#cite_note-Loirat2008-1\">&#91;1&#93;</a></sup> In recent years, some transplant centers have begun to administer eculizumab to patients with TMA who receive a kidney transplant. This strategy has been effective in preventing TMA recurrences in these patients.<sup id=\"cite_ref-Nester2011_34-0\" class=\"reference\"><a href=\"#cite_note-Nester2011-34\">&#91;34&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Prognosis\">Prognosis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Atypical_hemolytic_uremic_syndrome&amp;action=edit&amp;section=10\" title=\"Edit section: Prognosis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Patients with aHUS have an extremely poor prognosis. Among those with the most commonly identified aHUS genetic mutation, the proportion of patients experiencing negative outcomes (e.g., need for dialysis, permanent kidney damage, death) within the first year rises to 70%.<sup id=\"cite_ref-Caprioli2006_5-5\" class=\"reference\"><a href=\"#cite_note-Caprioli2006-5\">&#91;5&#93;</a></sup> However, sudden morbidity and mortality can occur regardless of mutational status. aHUS can arise at any age, with more than 40% of cases first reported after 18 years of age.<sup id=\"cite_ref-Noris2010_4-8\" class=\"reference\"><a href=\"#cite_note-Noris2010-4\">&#91;4&#93;</a></sup> The oldest presentation in one study was at age 83.<sup id=\"cite_ref-Noris2010_4-9\" class=\"reference\"><a href=\"#cite_note-Noris2010-4\">&#91;4&#93;</a></sup> As noted above, kidney transplantation for aHUS patients with ESRD was rarely considered because of a high incidence of graft loss due to TMA recurrence in the transplanted organ in up to 90% of patients.<sup id=\"cite_ref-Zuber2011_10-3\" class=\"reference\"><a href=\"#cite_note-Zuber2011-10\">&#91;10&#93;</a></sup><sup id=\"cite_ref-Kavanagh2010_33-1\" class=\"reference\"><a href=\"#cite_note-Kavanagh2010-33\">&#91;33&#93;</a></sup> Consequently, most aHUS patients with ESRD undergo chronic dialysis, which is associated with significant morbidities and worsened prognosis.<sup id=\"cite_ref-Zuber2011_10-4\" class=\"reference\"><a href=\"#cite_note-Zuber2011-10\">&#91;10&#93;</a></sup> Combined liver-kidney transplantation has been attempted in patients with aHUS, although this high-risk procedure has a mortality rate approaching 50%.<sup id=\"cite_ref-Bresin2006_35-0\" class=\"reference\"><a href=\"#cite_note-Bresin2006-35\">&#91;35&#93;</a></sup>\n</p><p>Quality of life is very poor for patients with aHUS, who are burdened with fatigue, renal complications, hypertension, neurological impairment, gastrointestinal distress, clotting at the site of venous access, and ultimately, death.<sup id=\"cite_ref-Caprioli2006_5-6\" class=\"reference\"><a href=\"#cite_note-Caprioli2006-5\">&#91;5&#93;</a></sup> PE/PI is also reported to be associated with significant safety risks and is highly disruptive to patients\u2019 lives due to the requirements for extensive vascular access and frequent administration.<sup id=\"cite_ref-Ariceta2009_11-3\" class=\"reference\"><a href=\"#cite_note-Ariceta2009-11\">&#91;11&#93;</a></sup><sup id=\"cite_ref-Bouts2011_36-0\" class=\"reference\"><a href=\"#cite_note-Bouts2011-36\">&#91;36&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Epidemiology\">Epidemiology</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Atypical_hemolytic_uremic_syndrome&amp;action=edit&amp;section=11\" title=\"Edit section: Epidemiology\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>aHUS can be inherited or acquired, and does not appear to vary by race, gender, or geographic area.<sup id=\"cite_ref-Noris2009_16-3\" class=\"reference\"><a href=\"#cite_note-Noris2009-16\">&#91;16&#93;</a></sup> As expected with an ultra-rare disease, data on the prevalence of aHUS are extremely limited. A pediatric prevalence of 3.3 cases per million population is documented in one publication of a European hemolytic uremic syndrome (HUS) registry involving 167 pediatric patients.<sup id=\"cite_ref-Zimm2006_37-0\" class=\"reference\"><a href=\"#cite_note-Zimm2006-37\">&#91;37&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Society_and_culture\">Society and culture</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Atypical_hemolytic_uremic_syndrome&amp;action=edit&amp;section=12\" title=\"Edit section: Society and culture\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Naming\">Naming</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Atypical_hemolytic_uremic_syndrome&amp;action=edit&amp;section=13\" title=\"Edit section: Naming\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Atypical hemolytic uremic syndrome (aHUS) has also been referred to as diarrhea-negative <a href=\"/wiki/Hemolytic-uremic_syndrome\" title=\"Hemolytic-uremic syndrome\">hemolytic-uremic syndrome</a> (D<sup>\u2212</sup> HUS).<sup id=\"cite_ref-Williams_2010_8_38-0\" class=\"reference\"><a href=\"#cite_note-Williams_2010_8-38\">&#91;38&#93;</a></sup><sup class=\"reference\" style=\"white-space:nowrap;\">:<span>2170</span></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Research_directions\">Research directions</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Atypical_hemolytic_uremic_syndrome&amp;action=edit&amp;section=14\" title=\"Edit section: Research directions\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Patient advocacy groups have been helping to determine research priorities.<sup id=\"cite_ref-39\" class=\"reference\"><a href=\"#cite_note-39\">&#91;39&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Atypical_hemolytic_uremic_syndrome&amp;action=edit&amp;section=15\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-Loirat2008-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Loirat2008_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Loirat2008_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Loirat2008_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Loirat2008_1-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Loirat2008_1-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Loirat2008_1-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-Loirat2008_1-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-Loirat2008_1-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-Loirat2008_1-8\"><sup><i><b>i</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Loirat C, Noris M, Fremeaux-Bacchi V (2008). \"Complement and the atypical hemolytic uremia syndrome in children\". <i>Pediatr Nephrol</i>. <b>23</b>: 1957\u20131972. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s00467-008-0872-4\">10.1007/s00467-008-0872-4</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18594873\">18594873</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pediatr+Nephrol&amp;rft.atitle=Complement+and+the+atypical+hemolytic+uremia+syndrome+in+children&amp;rft.volume=23&amp;rft.pages=1957-1972&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1007%2Fs00467-008-0872-4&amp;rft_id=info%3Apmid%2F18594873&amp;rft.aulast=Loirat&amp;rft.aufirst=C&amp;rft.au=Noris%2C+M&amp;rft.au=Fremeaux-Bacchi%2C+V&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Walport2001-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Walport2001_2-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Walport, MJ; Rosen, Fred S.; Walport, Mark J. (2001). \"Complement\". <i>N Engl J Med</i>. <b>344</b> (14): 1058\u20131066. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJM200104053441406\">10.1056/NEJM200104053441406</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11287977\">11287977</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=N+Engl+J+Med&amp;rft.atitle=Complement&amp;rft.volume=344&amp;rft.issue=14&amp;rft.pages=1058-1066&amp;rft.date=2001&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM200104053441406&amp;rft_id=info%3Apmid%2F11287977&amp;rft.aulast=Walport&amp;rft.aufirst=MJ&amp;rft.au=Rosen%2C+Fred+S.&amp;rft.au=Walport%2C+Mark+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Hosler2003-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Hosler2003_3-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hosler GA, Cusumano AM, Hutchins GM (2003). \"Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases\". <i>Arch. Pathol. Lab. Med</i>. <b>127</b> (7): 834\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1043/1543-2165%282003%29127%3C834%3ATTPAHU%3E2.0.CO%3B2\">10.1043/1543-2165(2003)127&#60;834:TTPAHU&#62;2.0.CO;2</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12823037\">12823037</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Arch.+Pathol.+Lab.+Med.&amp;rft.atitle=Thrombotic+thrombocytopenic+purpura+and+hemolytic+uremic+syndrome+are+distinct+pathologic+entities.+A+review+of+56+autopsy+cases&amp;rft.volume=127&amp;rft.issue=7&amp;rft.pages=834-9&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1043%2F1543-2165%282003%29127%3C834%3ATTPAHU%3E2.0.CO%3B2&amp;rft_id=info%3Apmid%2F12823037&amp;rft.aulast=Hosler&amp;rft.aufirst=GA&amp;rft.au=Cusumano%2C+AM&amp;rft.au=Hutchins%2C+GM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Noris2010-4\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Noris2010_4-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Noris2010_4-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Noris2010_4-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Noris2010_4-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Noris2010_4-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Noris2010_4-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-Noris2010_4-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-Noris2010_4-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-Noris2010_4-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-Noris2010_4-9\"><sup><i><b>j</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S,  et al. (October 2010). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2974386\">\"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype\"</a>. <i>Clin J Am Soc Nephrol</i>. <b>5</b> (10): 1844\u201359. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2215/CJN.02210310\">10.2215/CJN.02210310</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2974386\">2974386</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20595690\">20595690</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin+J+Am+Soc+Nephrol&amp;rft.atitle=Relative+role+of+genetic+complement+abnormalities+in+sporadic+and+familial+aHUS+and+their+impact+on+clinical+phenotype&amp;rft.volume=5&amp;rft.issue=10&amp;rft.pages=1844-59&amp;rft.date=2010-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2974386&amp;rft_id=info%3Apmid%2F20595690&amp;rft_id=info%3Adoi%2F10.2215%2FCJN.02210310&amp;rft.aulast=Noris&amp;rft.aufirst=M&amp;rft.au=Caprioli%2C+J&amp;rft.au=Bresin%2C+E&amp;rft.au=Mossali%2C+C&amp;rft.au=Pianetti%2C+G&amp;rft.au=Gamba%2C+S&amp;rft.au=Daina%2C+E&amp;rft.au=Fenili%2C+C&amp;rft.au=Castelletti%2C+F&amp;rft.au=Sorosina%2C+A&amp;rft.au=Piras%2C+R&amp;rft.au=Donadelli%2C+R&amp;rft.au=Maranta%2C+R&amp;rft.au=van+der+Meer%2C+I&amp;rft.au=Conway%2C+EM&amp;rft.au=Zipfel%2C+PF&amp;rft.au=Goodship%2C+TH&amp;rft.au=Remuzzi%2C+G&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2974386&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Caprioli2006-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Caprioli2006_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Caprioli2006_5-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Caprioli2006_5-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Caprioli2006_5-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Caprioli2006_5-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Caprioli2006_5-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-Caprioli2006_5-6\"><sup><i><b>g</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Caprioli, J; Noris, M; Brioschi, S; Pianetti, G; Castelletti, F; Bettinaglio, P; Mele, C; Bresin, E; Cassis, L; Gamba, S; Porrati, F; Bucchioni, S; Monteferrante, G; Fang, CJ; Liszewski, MK; Kavanagh, D; Atkinson, JP; Remuzzi, G; International Registry of Recurrent Familial HUS/TTP (2006). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1895874\">\"Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome\"</a>. <i>Blood</i>. <b>108</b> (4): 1267\u20131279. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1182/blood-2005-10-007252\">10.1182/blood-2005-10-007252</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1895874\">1895874</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16621965\">16621965</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Blood&amp;rft.atitle=Genetics+of+HUS%3A+the+impact+of+MCP%2C+CFH%2C+and+IF+mutations+on+clinical+presentation%2C+response+to+treatment%2C+and+outcome&amp;rft.volume=108&amp;rft.issue=4&amp;rft.pages=1267-1279&amp;rft.date=2006&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1895874&amp;rft_id=info%3Apmid%2F16621965&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2005-10-007252&amp;rft.aulast=Caprioli&amp;rft.aufirst=J&amp;rft.au=Noris%2C+M&amp;rft.au=Brioschi%2C+S&amp;rft.au=Pianetti%2C+G&amp;rft.au=Castelletti%2C+F&amp;rft.au=Bettinaglio%2C+P&amp;rft.au=Mele%2C+C&amp;rft.au=Bresin%2C+E&amp;rft.au=Cassis%2C+L&amp;rft.au=Gamba%2C+S&amp;rft.au=Porrati%2C+F&amp;rft.au=Bucchioni%2C+S&amp;rft.au=Monteferrante%2C+G&amp;rft.au=Fang%2C+CJ&amp;rft.au=Liszewski%2C+MK&amp;rft.au=Kavanagh%2C+D&amp;rft.au=Atkinson%2C+JP&amp;rft.au=Remuzzi%2C+G&amp;rft.au=International+Registry+of+Recurrent+Familial+HUS%2FTTP&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1895874&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Hoffman_2012_6-6\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Hoffman_2012_6_6-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Hoffman_2012_6_6-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Hoffman_2012_6_6-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">Hoffman, R; Benz, EJ; Silberstein, LE; Heslop, H; Weitz J; Anastasi, J. (2012). <i>Hematology: Basic Principles and Practice</i> (6th ed.). Elsevier. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-1-4377-2928-3\" title=\"Special:BookSources/978-1-4377-2928-3\">978-1-4377-2928-3</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Hematology%3A+Basic+Principles+and+Practice&amp;rft.edition=6th&amp;rft.pub=Elsevier&amp;rft.date=2012&amp;rft.isbn=978-1-4377-2928-3&amp;rft.aulast=Hoffman&amp;rft.aufirst=R&amp;rft.au=Benz%2C+EJ&amp;rft.au=Silberstein%2C+LE&amp;rft.au=Heslop%2C+H&amp;rft.au=Weitz+J&amp;rft.au=Anastasi%2C+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Ohanian2011-7\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Ohanian2011_7-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Ohanian2011_7-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Ohanian2011_7-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ohanian, M; Cable, C; Halka, K (2011). \"Eculizumab safely reverses neurologic impairment and eliminates the need for dialysis in severe atypical hemolytic uremic syndrome\". <i>Clin Pharmacol Adv App</i>. <b>5</b>: 687\u2013696.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin+Pharmacol+Adv+App&amp;rft.atitle=Eculizumab+safely+reverses+neurologic+impairment+and+eliminates+the+need+for+dialysis+in+severe+atypical+hemolytic+uremic+syndrome&amp;rft.volume=5&amp;rft.pages=687-696&amp;rft.date=2011&amp;rft.aulast=Ohanian&amp;rft.aufirst=M&amp;rft.au=Cable%2C+C&amp;rft.au=Halka%2C+K&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Stahl2008-8\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Stahl2008_8-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Stahl2008_8-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Stahl2008_8-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Stahl, AL; Vaziri-Sani, F; Heinen, S; Kristoffersson, AC; Gydell, KH; Raafat, R; Gutierrez, A; Beringer, O; Zipfel, PF; Karpman, D. (2008). \"Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement depositionn on platelets and their activation\". <i>Blood</i>. <b>111</b> (11): 5307\u20135315. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1182/blood-2007-08-106153\">10.1182/blood-2007-08-106153</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18268093\">18268093</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Blood&amp;rft.atitle=Factor+H+dysfunction+in+patients+with+atypical+hemolytic+uremic+syndrome+contributes+to+complement+depositionn+on+platelets+and+their+activation&amp;rft.volume=111&amp;rft.issue=11&amp;rft.pages=5307-5315&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2007-08-106153&amp;rft_id=info%3Apmid%2F18268093&amp;rft.aulast=Stahl&amp;rft.aufirst=AL&amp;rft.au=Vaziri-Sani%2C+F&amp;rft.au=Heinen%2C+S&amp;rft.au=Kristoffersson%2C+AC&amp;rft.au=Gydell%2C+KH&amp;rft.au=Raafat%2C+R&amp;rft.au=Gutierrez%2C+A&amp;rft.au=Beringer%2C+O&amp;rft.au=Zipfel%2C+PF&amp;rft.au=Karpman%2C+D.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Dragon2010-9\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Dragon2010_9-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Dragon2010_9-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Dragon-Durey, M-A; Sethi, SK; Bagga, A; Blanc, C; Blouin, J; Ranchin, B; Andr\u00e9, JL; Takagi, N; Cheong, HI; Hari, P.; Le Quintrec, M.; Niaudet, P.; Loirat, C.; Fridman, W. H.; Fr\u00e9meaux-Bacchi, V. (2010). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3014031\">\"Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome\"</a>. <i>J Am Soc Nephrol</i>. <b>21</b> (12): 2180\u20132187. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1681/ASN.2010030315\">10.1681/ASN.2010030315</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3014031\">3014031</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21051740\">21051740</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Am+Soc+Nephrol&amp;rft.atitle=Clinical+features+of+anti-factor+H+autoantibody-associated+hemolytic+uremic+syndrome&amp;rft.volume=21&amp;rft.issue=12&amp;rft.pages=2180-2187&amp;rft.date=2010&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3014031&amp;rft_id=info%3Apmid%2F21051740&amp;rft_id=info%3Adoi%2F10.1681%2FASN.2010030315&amp;rft.aulast=Dragon-Durey&amp;rft.aufirst=M-A&amp;rft.au=Sethi%2C+SK&amp;rft.au=Bagga%2C+A&amp;rft.au=Blanc%2C+C&amp;rft.au=Blouin%2C+J&amp;rft.au=Ranchin%2C+B&amp;rft.au=Andr%C3%A9%2C+JL&amp;rft.au=Takagi%2C+N&amp;rft.au=Cheong%2C+HI&amp;rft.au=Hari%2C+P.&amp;rft.au=Le+Quintrec%2C+M.&amp;rft.au=Niaudet%2C+P.&amp;rft.au=Loirat%2C+C.&amp;rft.au=Fridman%2C+W.+H.&amp;rft.au=Fr%C3%A9meaux-Bacchi%2C+V.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3014031&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Zuber2011-10\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Zuber2011_10-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Zuber2011_10-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Zuber2011_10-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Zuber2011_10-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Zuber2011_10-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Zuber, J; Le Quintrec, Moglie; Sberro-Soussan, Rebecca; Loirat, Chantal; Fr\u00e9meaux-Bacchi, V\u00e9ronique; Legendre, Christophe (2011). \"New insights into postrenal transplant hemolytic uremic syndrome\". <i>Nature Reviews Nephrology</i>. <b>7</b> (1): 23\u201325. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nrneph.2010.155\">10.1038/nrneph.2010.155</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21102542\">21102542</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Nephrology&amp;rft.atitle=New+insights+into+postrenal+transplant+hemolytic+uremic+syndrome&amp;rft.volume=7&amp;rft.issue=1&amp;rft.pages=23-25&amp;rft.date=2011&amp;rft_id=info%3Adoi%2F10.1038%2Fnrneph.2010.155&amp;rft_id=info%3Apmid%2F21102542&amp;rft.aulast=Zuber&amp;rft.aufirst=J&amp;rft.au=Le+Quintrec%2C+Moglie&amp;rft.au=Sberro-Soussan%2C+Rebecca&amp;rft.au=Loirat%2C+Chantal&amp;rft.au=Fr%C3%A9meaux-Bacchi%2C+V%C3%A9ronique&amp;rft.au=Legendre%2C+Christophe&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Ariceta2009-11\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Ariceta2009_11-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Ariceta2009_11-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Ariceta2009_11-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Ariceta2009_11-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ariceta, G; Besbas, N; Johnson, S; Karpman, D; Landau, D; Licht, C; Loirat, C; Pecoraro, C; Taylor, CM; Van De Kar, Nicole; Vandewalle, Johan; Zimmerhackl, Lothar B.; European Paediatric Study Group for HUS (2009). \"Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome\". <i>Pediatr Nephrol</i>. <b>24</b> (4): 687\u2013696. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s00467-008-0964-1\">10.1007/s00467-008-0964-1</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18800230\">18800230</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pediatr+Nephrol&amp;rft.atitle=Guideline+for+the+investigation+and+initial+therapy+of+diarrhea-negative+hemolytic+uremic+syndrome&amp;rft.volume=24&amp;rft.issue=4&amp;rft.pages=687-696&amp;rft.date=2009&amp;rft_id=info%3Adoi%2F10.1007%2Fs00467-008-0964-1&amp;rft_id=info%3Apmid%2F18800230&amp;rft.aulast=Ariceta&amp;rft.aufirst=G&amp;rft.au=Besbas%2C+N&amp;rft.au=Johnson%2C+S&amp;rft.au=Karpman%2C+D&amp;rft.au=Landau%2C+D&amp;rft.au=Licht%2C+C&amp;rft.au=Loirat%2C+C&amp;rft.au=Pecoraro%2C+C&amp;rft.au=Taylor%2C+CM&amp;rft.au=Van+De+Kar%2C+Nicole&amp;rft.au=Vandewalle%2C+Johan&amp;rft.au=Zimmerhackl%2C+Lothar+B.&amp;rft.au=European+Paediatric+Study+Group+for+HUS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Sellier2007-12\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Sellier2007_12-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Sellier2007_12-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Sellier2007_12-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Sellier2007_12-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sellier-Leclerc, AL; Fremeaux-Bacchi, V; Dragon-Durey, MA; Macher, MA; Niaudet, P; Guest, G; Boudailliez, B; Bouissou, F; Deschenes, G; Gie, S.; Tsimaratos, M.; Fischbach, M.; Morin, D.; Nivet, H.; Alberti, C.; Loirat, C.; French Society of Pediatric Nephrology (2007). \"Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome\". <i>J Am Soc Nephrol</i>. <b>18</b> (8): 2392\u20132400. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1681/ASN.2006080811\">10.1681/ASN.2006080811</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17599974\">17599974</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Am+Soc+Nephrol&amp;rft.atitle=Differential+impact+of+complement+mutations+on+clinical+characteristics+in+atypical+hemolytic+uremic+syndrome&amp;rft.volume=18&amp;rft.issue=8&amp;rft.pages=2392-2400&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1681%2FASN.2006080811&amp;rft_id=info%3Apmid%2F17599974&amp;rft.aulast=Sellier-Leclerc&amp;rft.aufirst=AL&amp;rft.au=Fremeaux-Bacchi%2C+V&amp;rft.au=Dragon-Durey%2C+MA&amp;rft.au=Macher%2C+MA&amp;rft.au=Niaudet%2C+P&amp;rft.au=Guest%2C+G&amp;rft.au=Boudailliez%2C+B&amp;rft.au=Bouissou%2C+F&amp;rft.au=Deschenes%2C+G&amp;rft.au=Gie%2C+S.&amp;rft.au=Tsimaratos%2C+M.&amp;rft.au=Fischbach%2C+M.&amp;rft.au=Morin%2C+D.&amp;rft.au=Nivet%2C+H.&amp;rft.au=Alberti%2C+C.&amp;rft.au=Loirat%2C+C.&amp;rft.au=French+Society+of+Pediatric+Nephrology&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Sallee2010-13\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Sallee2010_13-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Sallee2010_13-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sallee, M; Daniel, L; Piercecchi, MD; Jaubert, D; Fremeaux-Bacchi, V; Berland, Y; Burtey, S (2010). \"Myocardial infarction is a complication of factor H-associated atypical HUS\". <i>Nephrol Dial Transplant</i>. <b>25</b> (6): 2028\u20132032. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/ndt/gfq160\">10.1093/ndt/gfq160</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20305136\">20305136</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nephrol+Dial+Transplant&amp;rft.atitle=Myocardial+infarction+is+a+complication+of+factor+H-associated+atypical+HUS&amp;rft.volume=25&amp;rft.issue=6&amp;rft.pages=2028-2032&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1093%2Fndt%2Fgfq160&amp;rft_id=info%3Apmid%2F20305136&amp;rft.aulast=Sallee&amp;rft.aufirst=M&amp;rft.au=Daniel%2C+L&amp;rft.au=Piercecchi%2C+MD&amp;rft.au=Jaubert%2C+D&amp;rft.au=Fremeaux-Bacchi%2C+V&amp;rft.au=Berland%2C+Y&amp;rft.au=Burtey%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Neuhaus1997-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Neuhaus1997_14-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Neuhaus, TJ; Calonder, S; Leumann, EP (1997). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1717216\">\"Heterogeneity of atypical haemolytic uraemic syndromes\"</a>. <i>Arch Dis Child</i>. <b>76</b> (6): 518\u2013521. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1136/adc.76.6.518\">10.1136/adc.76.6.518</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1717216\">1717216</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9245850\">9245850</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Arch+Dis+Child&amp;rft.atitle=Heterogeneity+of+atypical+haemolytic+uraemic+syndromes&amp;rft.volume=76&amp;rft.issue=6&amp;rft.pages=518-521&amp;rft.date=1997&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1717216&amp;rft_id=info%3Apmid%2F9245850&amp;rft_id=info%3Adoi%2F10.1136%2Fadc.76.6.518&amp;rft.aulast=Neuhaus&amp;rft.aufirst=TJ&amp;rft.au=Calonder%2C+S&amp;rft.au=Leumann%2C+EP&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1717216&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Noris2005-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Noris2005_15-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Noris, M; Remuzzi, G (2005). \"Hemolytic uremic syndrome\". <i>J Am Soc Nephrol</i>. <b>16</b> (4): 1035\u20131050. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1681/ASN.2004100861\">10.1681/ASN.2004100861</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15728781\">15728781</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Am+Soc+Nephrol&amp;rft.atitle=Hemolytic+uremic+syndrome&amp;rft.volume=16&amp;rft.issue=4&amp;rft.pages=1035-1050&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1681%2FASN.2004100861&amp;rft_id=info%3Apmid%2F15728781&amp;rft.aulast=Noris&amp;rft.aufirst=M&amp;rft.au=Remuzzi%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Noris2009-16\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Noris2009_16-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Noris2009_16-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Noris2009_16-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Noris2009_16-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Noris, M; Remuzzi, G (2009). \"Atypical hemolytic-uremic syndrome\". <i>N Engl J Med</i>. <b>361</b> (17): 1676\u20131687. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMra0902814\">10.1056/NEJMra0902814</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19846853\">19846853</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=N+Engl+J+Med&amp;rft.atitle=Atypical+hemolytic-uremic+syndrome&amp;rft.volume=361&amp;rft.issue=17&amp;rft.pages=1676-1687&amp;rft.date=2009&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMra0902814&amp;rft_id=info%3Apmid%2F19846853&amp;rft.aulast=Noris&amp;rft.aufirst=M&amp;rft.au=Remuzzi%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Benz2010-17\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Benz2010_17-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Benz2010_17-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Benz2010_17-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Benz, K; Amann, K (2010). \"Thrombotic microangiopathy: new insights\". <i>Current Opinion in Nephrology and Hypertension</i>. <b>19</b> (3): 242\u2013247. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/MNH.0b013e3283378f25\">10.1097/MNH.0b013e3283378f25</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20186056\">20186056</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Nephrology+and+Hypertension&amp;rft.atitle=Thrombotic+microangiopathy%3A+new+insights&amp;rft.volume=19&amp;rft.issue=3&amp;rft.pages=242-247&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1097%2FMNH.0b013e3283378f25&amp;rft_id=info%3Apmid%2F20186056&amp;rft.aulast=Benz&amp;rft.aufirst=K&amp;rft.au=Amann%2C+K&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Mache2009-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Mache2009_18-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Mache, CJ; Acham-Roschitz, B.; Fremeaux-Bacchi, V; Kirschfink, M; Zipfel, PF; Roedl, S; Vester, U; Ring, E (2009). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2723971\">\"Complement inhibitor eculizumab in atypical hemolytic uremic syndrome\"</a>. <i>CJASN -- Clin J Amer Soc Nephrol</i>. <b>4</b> (8): 1312\u20131316. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2215/CJN.01090209\">10.2215/CJN.01090209</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2723971\">2723971</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CJASN+--+Clin+J+Amer+Soc+Nephrol&amp;rft.atitle=Complement+inhibitor+eculizumab+in+atypical+hemolytic+uremic+syndrome&amp;rft.volume=4&amp;rft.issue=8&amp;rft.pages=1312-1316&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2723971&amp;rft_id=info%3Adoi%2F10.2215%2FCJN.01090209&amp;rft.aulast=Mache&amp;rft.aufirst=CJ&amp;rft.au=Acham-Roschitz%2C+B.&amp;rft.au=Fremeaux-Bacchi%2C+V&amp;rft.au=Kirschfink%2C+M&amp;rft.au=Zipfel%2C+PF&amp;rft.au=Roedl%2C+S&amp;rft.au=Vester%2C+U&amp;rft.au=Ring%2C+E&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2723971&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Zipfel2010-19\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Zipfel2010_19-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Zipfel2010_19-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Zipfel, PF; Heinen, S; Skerka, C (2010). \"Thrombotic microangiopathies:new insights and new challenges\". <i>Current Opinion in Nephrology and Hypertension</i>. <b>19</b> (4): 372\u2013378. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/MNH.0b013e32833aff4a\">10.1097/MNH.0b013e32833aff4a</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20539230\">20539230</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Nephrology+and+Hypertension&amp;rft.atitle=Thrombotic+microangiopathies%3Anew+insights+and+new+challenges&amp;rft.volume=19&amp;rft.issue=4&amp;rft.pages=372-378&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1097%2FMNH.0b013e32833aff4a&amp;rft_id=info%3Apmid%2F20539230&amp;rft.aulast=Zipfel&amp;rft.aufirst=PF&amp;rft.au=Heinen%2C+S&amp;rft.au=Skerka%2C+C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Tsai2010-20\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Tsai2010_20-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Tsai2010_20-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Tsai2010_20-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Tsai, H-M (2010). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3159000\">\"Pathophysiology of thrombotic thrombocytopenic purpura\"</a>. <i>Int J Hematol</i>. <b>91</b> (1): 1\u201319. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s12185-009-0476-1\">10.1007/s12185-009-0476-1</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3159000\">3159000</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20058209\">20058209</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Int+J+Hematol&amp;rft.atitle=Pathophysiology+of+thrombotic+thrombocytopenic+purpura&amp;rft.volume=91&amp;rft.issue=1&amp;rft.pages=1-19&amp;rft.date=2010&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3159000&amp;rft_id=info%3Apmid%2F20058209&amp;rft_id=info%3Adoi%2F10.1007%2Fs12185-009-0476-1&amp;rft.aulast=Tsai&amp;rft.aufirst=H-M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3159000&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-George2010-21\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-George2010_21-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-George2010_21-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-George2010_21-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">George, JN (2010). \"How I treat patients with thrombotic thrombocytopenic purpura\". <i>Blood</i>. <b>116</b> (20): 4060\u20134069. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1182/blood-2010-07-271445\">10.1182/blood-2010-07-271445</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20686117\">20686117</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Blood&amp;rft.atitle=How+I+treat+patients+with+thrombotic+thrombocytopenic+purpura&amp;rft.volume=116&amp;rft.issue=20&amp;rft.pages=4060-4069&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2010-07-271445&amp;rft_id=info%3Apmid%2F20686117&amp;rft.aulast=George&amp;rft.aufirst=JN&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Moake2004-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Moake2004_22-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Moake, JL (2004). \"von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura\". <i>Semin Hematol</i>. <b>41</b> (1): 4\u201314. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1053/j.seminhematol.2003.10.003\">10.1053/j.seminhematol.2003.10.003</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14727254\">14727254</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Semin+Hematol&amp;rft.atitle=von+Willebrand+factor%2C+ADAMTS-13%2C+and+thrombotic+thrombocytopenic+purpura&amp;rft.volume=41&amp;rft.issue=1&amp;rft.pages=4-14&amp;rft.date=2004&amp;rft_id=info%3Adoi%2F10.1053%2Fj.seminhematol.2003.10.003&amp;rft_id=info%3Apmid%2F14727254&amp;rft.aulast=Moake&amp;rft.aufirst=JL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Fang2008-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Fang2008_23-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fang CJ, Fremeaux-Bacchi V, Liszewski MK,  et al. (2008). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2200836\">\"Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome\"</a>. <i>Blood</i>. <b>111</b> (2): 624\u2013632. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1182/blood-2007-04-084533\">10.1182/blood-2007-04-084533</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2200836\">2200836</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17914026\">17914026</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Blood&amp;rft.atitle=Membrane+cofactor+protein+mutations+in+atypical+hemolytic+uremic+syndrome+%28aHUS%29%2C+fatal+Stx-HUS%2C+C3+glomerulonephritis%2C+and+the+HELLP+syndrome&amp;rft.volume=111&amp;rft.issue=2&amp;rft.pages=624-632&amp;rft.date=2008&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2200836&amp;rft_id=info%3Apmid%2F17914026&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2007-04-084533&amp;rft.aulast=Fang&amp;rft.aufirst=CJ&amp;rft.au=Fremeaux-Bacchi%2C+V&amp;rft.au=Liszewski%2C+MK&amp;rft.au=Pianetti%2C+G&amp;rft.au=Noris%2C+M&amp;rft.au=Goodship%2C+TH&amp;rft.au=Atkinson%2C+JP&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2200836&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Bitzan2010-24\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Bitzan2010_24-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Bitzan2010_24-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bitzan, M; Schaefer, Franz; Reymond, Didier (2010). \"Treatment of typical (enteropathic) hemolytic uremic syndrome\". <i>Semin Thromb Hemostas</i>. <b>36</b> (6): 594\u2013610. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1055/s-0030-1262881\">10.1055/s-0030-1262881</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20865636\">20865636</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Semin+Thromb+Hemostas&amp;rft.atitle=Treatment+of+typical+%28enteropathic%29+hemolytic+uremic+syndrome&amp;rft.volume=36&amp;rft.issue=6&amp;rft.pages=594-610&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1055%2Fs-0030-1262881&amp;rft_id=info%3Apmid%2F20865636&amp;rft.aulast=Bitzan&amp;rft.aufirst=M&amp;rft.au=Schaefer%2C+Franz&amp;rft.au=Reymond%2C+Didier&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Szczepiorkowski2010-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Szczepiorkowski2010_25-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Szczepiorkowski, ZM; Winters, Jeffrey L.; Bandarenko, Nicholas; Kim, Haewon C.; Linenberger, Michael L.; Marques, Marisa B.; Sarode, Ravindra; Schwartz, Joseph; Weinstein, Robert; Shaz, Beth H.; Apheresis Applications Committee of the American Society for Apheresis (2010). \"Guidelines on the use of therapeutic apheresis in clinical practice- evidence based approach from the Apheresis Applications Committee of the American Society of Apheresis\". <i>J Clin SPheresis</i>. <b>25</b> (3): 83\u2013177. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/jca.20240\">10.1002/jca.20240</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20568098\">20568098</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Clin+SPheresis&amp;rft.atitle=Guidelines+on+the+use+of+therapeutic+apheresis+in+clinical+practice-+evidence+based+approach+from+the+Apheresis+Applications+Committee+of+the+American+Society+of+Apheresis&amp;rft.volume=25&amp;rft.issue=3&amp;rft.pages=83-177&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1002%2Fjca.20240&amp;rft_id=info%3Apmid%2F20568098&amp;rft.aulast=Szczepiorkowski&amp;rft.aufirst=ZM&amp;rft.au=Winters%2C+Jeffrey+L.&amp;rft.au=Bandarenko%2C+Nicholas&amp;rft.au=Kim%2C+Haewon+C.&amp;rft.au=Linenberger%2C+Michael+L.&amp;rft.au=Marques%2C+Marisa+B.&amp;rft.au=Sarode%2C+Ravindra&amp;rft.au=Schwartz%2C+Joseph&amp;rft.au=Weinstein%2C+Robert&amp;rft.au=Shaz%2C+Beth+H.&amp;rft.au=Apheresis+Applications+Committee+of+the+American+Society+for+Apheresis&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Michon2007-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Michon2007_26-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Michon, B; Moghrabi, A; Winikoff, R; Barrette, S; Bernstein, ML; Champagne, J; David, M; Duval, M; Hume, HA; Robitaille, Nancy; B\u00e9lisle, Andr\u00e9; Champagne, Martin A. (2007). \"Complications of apheresis in children\". <i>Transfusion</i>. <b>47</b> (10): 1837\u20131842. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1537-2995.2007.01405.x\">10.1111/j.1537-2995.2007.01405.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17880609\">17880609</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Transfusion&amp;rft.atitle=Complications+of+apheresis+in+children&amp;rft.volume=47&amp;rft.issue=10&amp;rft.pages=1837-1842&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1537-2995.2007.01405.x&amp;rft_id=info%3Apmid%2F17880609&amp;rft.aulast=Michon&amp;rft.aufirst=B&amp;rft.au=Moghrabi%2C+A&amp;rft.au=Winikoff%2C+R&amp;rft.au=Barrette%2C+S&amp;rft.au=Bernstein%2C+ML&amp;rft.au=Champagne%2C+J&amp;rft.au=David%2C+M&amp;rft.au=Duval%2C+M&amp;rft.au=Hume%2C+HA&amp;rft.au=Robitaille%2C+Nancy&amp;rft.au=B%C3%A9lisle%2C+Andr%C3%A9&amp;rft.au=Champagne%2C+Martin+A.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Licht2009-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Licht2009_27-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Licht, C; Pluthero, FG; Li, L; Christensen, H; Habbig, S; Hoppe, B; Geary, DF; Zipfel, PF; Kahr, WH (2009). \"Platelet-associated complement factor H in healthy persons and patients with atypical HUS\". <i>Blood</i>. <b>114</b> (20): 4538\u20134545. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1182/blood-2009-03-205096\">10.1182/blood-2009-03-205096</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19704120\">19704120</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Blood&amp;rft.atitle=Platelet-associated+complement+factor+H+in+healthy+persons+and+patients+with+atypical+HUS&amp;rft.volume=114&amp;rft.issue=20&amp;rft.pages=4538-4545&amp;rft.date=2009&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2009-03-205096&amp;rft_id=info%3Apmid%2F19704120&amp;rft.aulast=Licht&amp;rft.aufirst=C&amp;rft.au=Pluthero%2C+FG&amp;rft.au=Li%2C+L&amp;rft.au=Christensen%2C+H&amp;rft.au=Habbig%2C+S&amp;rft.au=Hoppe%2C+B&amp;rft.au=Geary%2C+DF&amp;rft.au=Zipfel%2C+PF&amp;rft.au=Kahr%2C+WH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Drug2013-28\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Drug2013_28-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Drug2013_28-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Keating, GM (December 2013). \"Eculizumab: a review of its use in atypical haemolytic uraemic syndrome\". <i>Drugs</i>. <b>73</b> (18): 2053\u201366. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s40265-013-0147-7\">10.1007/s40265-013-0147-7</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24249647\">24249647</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drugs&amp;rft.atitle=Eculizumab%3A+a+review+of+its+use+in+atypical+haemolytic+uraemic+syndrome.&amp;rft.volume=73&amp;rft.issue=18&amp;rft.pages=2053-66&amp;rft.date=2013-12&amp;rft_id=info%3Adoi%2F10.1007%2Fs40265-013-0147-7&amp;rft_id=info%3Apmid%2F24249647&amp;rft.aulast=Keating&amp;rft.aufirst=GM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-FDA_2011-29\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-FDA_2011_29-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm272990.htm\">\"FDA approves Soliris for rare pediatric blood disorder: Orphan drug receives second approval for rare disease\"</a>, <i>FDA</i>, 23 September 2011<span class=\"reference-accessdate\">, retrieved <span class=\"nowrap\">25 June</span> 2015</span></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FDA&amp;rft.atitle=FDA+approves+Soliris+for+rare+pediatric+blood+disorder%3A+Orphan+drug+receives+second+approval+for+rare+disease&amp;rft.date=2011-09-23&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm272990.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Collins2010-30\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Collins2010_30-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Collins, AJ; Foley, Robert N.; Herzog, Charles; Chavers, Blanche M; Gilbertson, David; Ishani, Areef; Kasiske, Bertram L.; Liu, Jiannong; Mau, Lih-Wen; McBean, Marshall (2010). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2829836\">\"Excerpts from the US Renal Data System 2009 annual report\"</a>. <i>Am J Kidney Dis</i>. <b>55</b>: S1\u2013S7. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1053/j.ajkd.2009.10.009\">10.1053/j.ajkd.2009.10.009</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2829836\">2829836</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am+J+Kidney+Dis&amp;rft.atitle=Excerpts+from+the+US+Renal+Data+System+2009+annual+report&amp;rft.volume=55&amp;rft.pages=S1-S7&amp;rft.date=2010&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2829836&amp;rft_id=info%3Adoi%2F10.1053%2Fj.ajkd.2009.10.009&amp;rft.aulast=Collins&amp;rft.aufirst=AJ&amp;rft.au=Foley%2C+Robert+N.&amp;rft.au=Herzog%2C+Charles&amp;rft.au=Chavers%2C+Blanche+M&amp;rft.au=Gilbertson%2C+David&amp;rft.au=Ishani%2C+Areef&amp;rft.au=Kasiske%2C+Bertram+L.&amp;rft.au=Liu%2C+Jiannong&amp;rft.au=Mau%2C+Lih-Wen&amp;rft.au=McBean%2C+Marshall&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2829836&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-European2011-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-European2011_31-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">\"European Renal Association-European Dialysis and Transplant Association Registry\". <i>ERA-EDTA Registry Annual Report 2009</i>. The Netherlands: Academic Medical Center, Department of Medical Informatics. 2011.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=ERA-EDTA+Registry+Annual+Report+2009&amp;rft.atitle=European+Renal+Association-European+Dialysis+and+Transplant+Association+Registry&amp;rft.date=2011&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Klevens2008-32\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Klevens2008_32-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Klevens, RM; Edwards, JR; Andrus, ML; Peterson, KD; Dudeck, MA; Horan, TC; NHSN Participants in Outpatient Dialysis Surveillance (2008). \"Dialysis surveillance report: National Healthcare Safety Network (NHSN)- data summary for 2006\". <i>Semin Dial</i>. <b>21</b> (1): 24\u201328. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1525-139X.2007.00379.x\">10.1111/j.1525-139X.2007.00379.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18251954\">18251954</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Semin+Dial&amp;rft.atitle=Dialysis+surveillance+report%3A+National+Healthcare+Safety+Network+%28NHSN%29-+data+summary+for+2006&amp;rft.volume=21&amp;rft.issue=1&amp;rft.pages=24-28&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1525-139X.2007.00379.x&amp;rft_id=info%3Apmid%2F18251954&amp;rft.aulast=Klevens&amp;rft.aufirst=RM&amp;rft.au=Edwards%2C+JR&amp;rft.au=Andrus%2C+ML&amp;rft.au=Peterson%2C+KD&amp;rft.au=Dudeck%2C+MA&amp;rft.au=Horan%2C+TC&amp;rft.au=NHSN+Participants+in+Outpatient+Dialysis+Surveillance&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Kavanagh2010-33\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Kavanagh2010_33-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Kavanagh2010_33-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kavanagh, D; Richards, A; Goodship, T; Jalanko, H (2010). \"Transplantation in atypical hemolytic uremic syndrome\". <i>Semin Thromb Hemost</i>. <b>36</b> (6): 653\u2013659. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1055/s-0030-1262887\">10.1055/s-0030-1262887</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20865642\">20865642</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Semin+Thromb+Hemost&amp;rft.atitle=Transplantation+in+atypical+hemolytic+uremic+syndrome&amp;rft.volume=36&amp;rft.issue=6&amp;rft.pages=653-659&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1055%2Fs-0030-1262887&amp;rft_id=info%3Apmid%2F20865642&amp;rft.aulast=Kavanagh&amp;rft.aufirst=D&amp;rft.au=Richards%2C+A&amp;rft.au=Goodship%2C+T&amp;rft.au=Jalanko%2C+H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Nester2011-34\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Nester2011_34-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Nester, C; Stewart, Z; Myers, D; Jetton, J; Nair, R; Reed, A; Thomas, C; Smith, R; Brophy, P (2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3109948\">\"Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic syndrome\"</a>. <i>Clin J Am Soc Nephrol</i>. <b>6</b> (6): 1488\u20131494. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2215/CJN.10181110\">10.2215/CJN.10181110</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3109948\">3109948</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21617085\">21617085</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin+J+Am+Soc+Nephrol&amp;rft.atitle=Pre-emptive+eculizumab+and+plasmapheresis+for+renal+transplant+in+atypical+hemolytic+syndrome&amp;rft.volume=6&amp;rft.issue=6&amp;rft.pages=1488-1494&amp;rft.date=2011&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3109948&amp;rft_id=info%3Apmid%2F21617085&amp;rft_id=info%3Adoi%2F10.2215%2FCJN.10181110&amp;rft.aulast=Nester&amp;rft.aufirst=C&amp;rft.au=Stewart%2C+Z&amp;rft.au=Myers%2C+D&amp;rft.au=Jetton%2C+J&amp;rft.au=Nair%2C+R&amp;rft.au=Reed%2C+A&amp;rft.au=Thomas%2C+C&amp;rft.au=Smith%2C+R&amp;rft.au=Brophy%2C+P&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3109948&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Bresin2006-35\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Bresin2006_35-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bresin, E; Daina, E; Noris, M; Castelletti, F; Stefanov, R; Hill, P; Goodship, TH; Remuzzi, G; International Registry of Recurrent Familial HUS/TTP (2006). \"Outcome of renal transplantation in patients with non- Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background\". <i>Clin J Am Soc Nephrol</i>. <b>1</b> (1): 88\u201399. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2215/CJN.00050505\">10.2215/CJN.00050505</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17699195\">17699195</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin+J+Am+Soc+Nephrol&amp;rft.atitle=Outcome+of+renal+transplantation+in+patients+with+non-+Shiga+toxin-associated+hemolytic+uremic+syndrome%3A+prognostic+significance+of+genetic+background&amp;rft.volume=1&amp;rft.issue=1&amp;rft.pages=88-99&amp;rft.date=2006&amp;rft_id=info%3Adoi%2F10.2215%2FCJN.00050505&amp;rft_id=info%3Apmid%2F17699195&amp;rft.aulast=Bresin&amp;rft.aufirst=E&amp;rft.au=Daina%2C+E&amp;rft.au=Noris%2C+M&amp;rft.au=Castelletti%2C+F&amp;rft.au=Stefanov%2C+R&amp;rft.au=Hill%2C+P&amp;rft.au=Goodship%2C+TH&amp;rft.au=Remuzzi%2C+G&amp;rft.au=International+Registry+of+Recurrent+Familial+HUS%2FTTP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Bouts2011-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Bouts2011_36-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bouts, A; Monnens, Leo; Davin, Jean-Claude; Struijk, Geertrude; Spanjaard, Lodewijk (2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3163808\">\"Insufficient protection by Neisseria meningitidis vaccination alone during eculizumab therapy\"</a>. <i>Pediatr Nephrol</i>. <b>26</b> (10): 1919\u20131920. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s00467-011-1929-3\">10.1007/s00467-011-1929-3</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3163808\">3163808</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21643943\">21643943</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pediatr+Nephrol&amp;rft.atitle=Insufficient+protection+by+Neisseria+meningitidis+vaccination+alone+during+eculizumab+therapy&amp;rft.volume=26&amp;rft.issue=10&amp;rft.pages=1919-1920&amp;rft.date=2011&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3163808&amp;rft_id=info%3Apmid%2F21643943&amp;rft_id=info%3Adoi%2F10.1007%2Fs00467-011-1929-3&amp;rft.aulast=Bouts&amp;rft.aufirst=A&amp;rft.au=Monnens%2C+Leo&amp;rft.au=Davin%2C+Jean-Claude&amp;rft.au=Struijk%2C+Geertrude&amp;rft.au=Spanjaard%2C+Lodewijk&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3163808&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Zimm2006-37\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Zimm2006_37-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Zimmerhackl, LR; Besbas, N; Jungraithmayr, T; Van De Kar, N; Karch, H; Karpman, D; Landau, D; Loirat, C; Proesmans, W; Pr\u00fcfer, Friederike; Rizzoni, Gianfranco; Taylor, Mark; European Study Group for Haemolytic Uraemic Syndromes Related Disorders (2006). \"Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome\". <i>Semin Thromb Hemost</i>. <b>32</b> (2): 113\u2013120. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1055/s-2006-939767\">10.1055/s-2006-939767</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16575686\">16575686</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Semin+Thromb+Hemost&amp;rft.atitle=Epidemiology%2C+clinical+presentation%2C+and+pathophysiology+of+atypical+and+recurrent+hemolytic+uremic+syndrome&amp;rft.volume=32&amp;rft.issue=2&amp;rft.pages=113-120&amp;rft.date=2006&amp;rft_id=info%3Adoi%2F10.1055%2Fs-2006-939767&amp;rft_id=info%3Apmid%2F16575686&amp;rft.aulast=Zimmerhackl&amp;rft.aufirst=LR&amp;rft.au=Besbas%2C+N&amp;rft.au=Jungraithmayr%2C+T&amp;rft.au=Van+De+Kar%2C+N&amp;rft.au=Karch%2C+H&amp;rft.au=Karpman%2C+D&amp;rft.au=Landau%2C+D&amp;rft.au=Loirat%2C+C&amp;rft.au=Proesmans%2C+W&amp;rft.au=Pr%C3%BCfer%2C+Friederike&amp;rft.au=Rizzoni%2C+Gianfranco&amp;rft.au=Taylor%2C+Mark&amp;rft.au=European+Study+Group+for+Haemolytic+Uraemic+Syndromes+Related+Disorders&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Williams_2010_8-38\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Williams_2010_8_38-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Kaushansky, K; Lichtman, M; Beutler, E; Kipps, T; Prchal, J; Seligsohn, U. (2010). <i>Williams Hematology</i> (8th ed.). McGraw-Hill. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-0071621519\" title=\"Special:BookSources/978-0071621519\">978-0071621519</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Williams+Hematology&amp;rft.edition=8th&amp;rft.pub=McGraw-Hill&amp;rft.date=2010&amp;rft.isbn=978-0071621519&amp;rft.aulast=Kaushansky&amp;rft.aufirst=K&amp;rft.au=Lichtman%2C+M&amp;rft.au=Beutler%2C+E&amp;rft.au=Kipps%2C+T&amp;rft.au=Prchal%2C+J&amp;rft.au=Seligsohn%2C+U.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-39\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-39\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Woodward, Len (2016). <a rel=\"nofollow\" class=\"external text\" href=\"http://rdcu.be/mPZG\">\"An innovative and collaborative partnership between patients with rare disease and industry-supported registries: the Global aHUS Registry\"</a>. <i>Orphanet Journal of Rare Diseases</i>. <b>11</b>: 154. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1186/s13023-016-0537-5\">10.1186/s13023-016-0537-5</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Orphanet+Journal+of+Rare+Diseases&amp;rft.atitle=An+innovative+and+collaborative+partnership+between+patients+with+rare+disease+and+industry-supported+registries%3A+the+Global+aHUS+Registry&amp;rft.volume=11&amp;rft.pages=154&amp;rft.date=2016&amp;rft_id=info%3Adoi%2F10.1186%2Fs13023-016-0537-5&amp;rft.aulast=Woodward&amp;rft.aufirst=Len&amp;rft_id=http%3A%2F%2Frdcu.be%2FmPZG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtypical+hemolytic+uremic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Atypical_hemolytic_uremic_syndrome&amp;action=edit&amp;section=16\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<table class=\"infobox\" style=\"width:22em;width:100%; margin:0 0 0.5em 0;\"><tbody><tr><th scope=\"row\">Classification</th><td style=\"text-align:left;\">\n<div style=\"position:relative; float:right; font-size:0.8em;\"><a href=\"https://www.wikidata.org/wiki/Q17165460\" class=\"extiw\" title=\"d:Q17165460\">D</a></div><div class=\"hlist hlist-separated\" style=\"text-align:left;\"><ul><li><b><a href=\"/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems\" title=\"International Statistical Classification of Diseases and Related Health Problems\">ICD</a>-<a href=\"/wiki/ICD-10\" title=\"ICD-10\">10</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"http://apps.who.int/classifications/icd10/browse/2016/en#/D59.3\">D59.3</a></li><li><b><a href=\"/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems\" title=\"International Statistical Classification of Diseases and Related Health Problems\">ICD</a>-<a href=\"/wiki/List_of_ICD-9_codes\" title=\"List of ICD-9 codes\">9-CM</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"http://www.icd9data.com/getICD9Code.ashx?icd9=283.11\">283.11</a></li></ul></div></td></tr><tr><th scope=\"row\">External resources</th><td style=\"text-align:left;\">\n<div class=\"hlist hlist-separated\" style=\"text-align:left;\"><ul><li><b><a href=\"/wiki/Orphanet\" title=\"Orphanet\">Orphanet</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=2134\">2134</a></li></ul></div></td></tr></tbody></table>\n\n<!-- \nNewPP limit report\nParsed by mw2234\nCached time: 20180921221422\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.592 seconds\nReal time usage: 0.657 seconds\nPreprocessor visited node count: 3369/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 102135/2097152 bytes\nTemplate argument size: 1190/2097152 bytes\nHighest expansion depth: 10/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 76409/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 0.279/10.000 seconds\nLua memory usage: 5.15 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  538.873      1 -total\n 59.70%  321.720      1 Template:Reflist\n 41.87%  225.623     36 Template:Cite_journal\n 23.21%  125.056      2 Template:Infobox\n 20.92%  112.744      1 Template:Infobox_medical_condition_(new)\n  7.35%   39.612      1 Template:Medical_resources\n  3.46%   18.657      2 Template:Hlist\n  2.11%   11.356      2 Template:Cite_book\n  1.82%    9.804      4 Template:Main_other\n  1.69%    9.097      1 Template:Citation\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:38187439-0!canonical and timestamp 20180921221421 and revision id 842499914\n -->\n</div>"},"langlinks":[{"lang":"cs","url":"https://cs.wikipedia.org/wiki/Atypick%C3%BD_hemolyticko-uremick%C3%BD_syndrom","langname":"Czech","autonym":"\u010de\u0161tina","*":"Atypick\u00fd hemolyticko-uremick\u00fd syndrom"},{"lang":"da","url":"https://da.wikipedia.org/wiki/Atypisk_h%C3%A6molytisk_ur%C3%A6misk_syndrom","langname":"Danish","autonym":"dansk","*":"Atypisk h\u00e6molytisk ur\u00e6misk syndrom"},{"lang":"el","url":"https://el.wikipedia.org/wiki/%CE%86%CF%84%CF%85%CF%80%CE%BF_%CE%B1%CE%B9%CE%BC%CE%BF%CE%BB%CF%85%CF%84%CE%B9%CE%BA%CF%8C_%CE%BF%CF%85%CF%81%CE%B1%CE%B9%CE%BC%CE%B9%CE%BA%CF%8C_%CF%83%CF%8D%CE%BD%CE%B4%CF%81%CE%BF%CE%BC%CE%BF","langname":"Greek","autonym":"\u0395\u03bb\u03bb\u03b7\u03bd\u03b9\u03ba\u03ac","*":"\u0386\u03c4\u03c5\u03c0\u03bf \u03b1\u03b9\u03bc\u03bf\u03bb\u03c5\u03c4\u03b9\u03ba\u03cc \u03bf\u03c5\u03c1\u03b1\u03b9\u03bc\u03b9\u03ba\u03cc \u03c3\u03cd\u03bd\u03b4\u03c1\u03bf\u03bc\u03bf"},{"lang":"fr","url":"https://fr.wikipedia.org/wiki/Syndrome_h%C3%A9molytique_et_ur%C3%A9mique_atypique","langname":"French","autonym":"fran\u00e7ais","*":"Syndrome h\u00e9molytique et ur\u00e9mique atypique"},{"lang":"ko","url":"https://ko.wikipedia.org/wiki/%EB%B9%84%EC%A0%95%ED%98%95_%EC%9A%A9%ED%98%88%EC%84%B1_%EC%9A%94%EB%8F%85%EC%A6%9D%ED%9B%84%EA%B5%B0","langname":"Korean","autonym":"\ud55c\uad6d\uc5b4","*":"\ube44\uc815\ud615 \uc6a9\ud608\uc131 \uc694\ub3c5\uc99d\ud6c4\uad70"},{"lang":"it","url":"https://it.wikipedia.org/wiki/Sindrome_emolitico-uremica_atipica","langname":"Italian","autonym":"italiano","*":"Sindrome emolitico-uremica atipica"},{"lang":"nl","url":"https://nl.wikipedia.org/wiki/Atypisch_hemolytisch-uremisch_syndroom","langname":"Dutch","autonym":"Nederlands","*":"Atypisch hemolytisch-uremisch syndroom"},{"lang":"no","url":"https://no.wikipedia.org/wiki/Atypisk_hemolytisk-uremisk_syndrom","langname":"Norwegian","autonym":"norsk","*":"Atypisk hemolytisk-uremisk syndrom"},{"lang":"pt","url":"https://pt.wikipedia.org/wiki/S%C3%ADndrome_hemol%C3%ADtico-ur%C3%AAmica_at%C3%ADpica","langname":"Portuguese","autonym":"portugu\u00eas","*":"S\u00edndrome hemol\u00edtico-ur\u00eamica at\u00edpica"},{"lang":"ru","url":"https://ru.wikipedia.org/wiki/%D0%90%D1%82%D0%B8%D0%BF%D0%B8%D1%87%D0%BD%D1%8B%D0%B9_%D0%B3%D0%B5%D0%BC%D0%BE%D0%BB%D0%B8%D1%82%D0%B8%D0%BA%D0%BE-%D1%83%D1%80%D0%B5%D0%BC%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B9_%D1%81%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BC","langname":"Russian","autonym":"\u0440\u0443\u0441\u0441\u043a\u0438\u0439","*":"\u0410\u0442\u0438\u043f\u0438\u0447\u043d\u044b\u0439 \u0433\u0435\u043c\u043e\u043b\u0438\u0442\u0438\u043a\u043e-\u0443\u0440\u0435\u043c\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0441\u0438\u043d\u0434\u0440\u043e\u043c"},{"lang":"sk","url":"https://sk.wikipedia.org/wiki/Atypick%C3%BD_hemolyticko-uremick%C3%BD_syndr%C3%B3m","langname":"Slovak","autonym":"sloven\u010dina","*":"Atypick\u00fd hemolyticko-uremick\u00fd syndr\u00f3m"},{"lang":"fi","url":"https://fi.wikipedia.org/wiki/Ep%C3%A4tyypillinen_hemolyyttis-ureeminen_oireyhtym%C3%A4","langname":"Finnish","autonym":"suomi","*":"Ep\u00e4tyypillinen hemolyyttis-ureeminen oireyhtym\u00e4"},{"lang":"sv","url":"https://sv.wikipedia.org/wiki/Atypiskt_hemolytiskt_uremiskt_syndrom","langname":"Swedish","autonym":"svenska","*":"Atypiskt hemolytiskt uremiskt syndrom"},{"lang":"tr","url":"https://tr.wikipedia.org/wiki/Atipik_hemolitik_%C3%BCremik_sendrom","langname":"Turkish","autonym":"T\u00fcrk\u00e7e","*":"Atipik hemolitik \u00fcremik sendrom"}],"categories":[{"sortkey":"","hidden":"","*":"Infobox_medical_condition_(new)"},{"sortkey":"","hidden":"","*":"Articles_created_via_the_Article_Wizard"},{"sortkey":"","*":"Blood_disorders"},{"sortkey":"","*":"Syndromes"}],"links":[{"ns":0,"exists":"","*":"ADAMTS13"},{"ns":0,"exists":"","*":"Complement system"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Eculizumab"},{"ns":0,"exists":"","*":"Endothelial cells"},{"ns":0,"exists":"","*":"Glomerulopathy"},{"ns":0,"exists":"","*":"Hematology"},{"ns":0,"exists":"","*":"Hemolysis"},{"ns":0,"exists":"","*":"Hemolytic-uremic syndrome"},{"ns":0,"exists":"","*":"ICD-10"},{"ns":0,"exists":"","*":"International Nonproprietary Name"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"International Statistical Classification of Diseases and Related Health Problems"},{"ns":0,"exists":"","*":"List of ICD-9 codes"},{"ns":0,"exists":"","*":"Monoclonal antibody"},{"ns":0,"exists":"","*":"Orphan drug"},{"ns":0,"exists":"","*":"Orphanet"},{"ns":0,"exists":"","*":"Plasma exchange"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"STEC-HUS"},{"ns":0,"exists":"","*":"Specialty (medicine)"},{"ns":0,"exists":"","*":"Systemic lupus erythematosus"},{"ns":0,"exists":"","*":"Systemic scleroderma"},{"ns":0,"exists":"","*":"Thrombotic microangiopathy"},{"ns":0,"exists":"","*":"Thrombotic thrombocytopenic purpura"},{"ns":0,"exists":"","*":"U.S. Food and Drug Administration"},{"ns":0,"exists":"","*":"USAN"},{"ns":0,"*":"Plasma infusion"}],"templates":[{"ns":10,"exists":"","*":"Template:Infobox medical condition (new)"},{"ns":10,"exists":"","*":"Template:Infobox"},{"ns":10,"exists":"","*":"Template:Template other"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Rp"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Citation"},{"ns":10,"exists":"","*":"Template:Medical resources"},{"ns":10,"exists":"","*":"Template:Hlist"},{"ns":10,"exists":"","*":"Template:ICD10"},{"ns":10,"exists":"","*":"Template:ICD9"},{"ns":10,"exists":"","*":"Template:Str find"},{"ns":828,"exists":"","*":"Module:Infobox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:InfoboxImage"},{"ns":828,"exists":"","*":"Module:String2"},{"ns":828,"exists":"","*":"Module:WikidataIB/sandbox"},{"ns":828,"exists":"","*":"Module:Complex date"},{"ns":828,"exists":"","*":"Module:I18n/complex date"},{"ns":828,"exists":"","*":"Module:Ordinal"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Roman"},{"ns":828,"exists":"","*":"Module:ISOdate"},{"ns":828,"exists":"","*":"Module:DateI18n"},{"ns":828,"exists":"","*":"Module:I18n/date"},{"ns":828,"exists":"","*":"Module:Calendar"},{"ns":828,"exists":"","*":"Module:I18n"},{"ns":828,"*":"Module:WikidataIB/i18n"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:List"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:String"}],"images":["Lock-green.svg","Blue_pencil.svg"],"externallinks":["//doi.org/10.1007/s00467-008-0872-4","//www.ncbi.nlm.nih.gov/pubmed/18594873","//doi.org/10.1056/NEJM200104053441406","//www.ncbi.nlm.nih.gov/pubmed/11287977","//doi.org/10.1043/1543-2165(2003)127%3C834:TTPAHU%3E2.0.CO;2","//www.ncbi.nlm.nih.gov/pubmed/12823037","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2974386","//doi.org/10.2215/CJN.02210310","//www.ncbi.nlm.nih.gov/pubmed/20595690","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1895874","//doi.org/10.1182/blood-2005-10-007252","//www.ncbi.nlm.nih.gov/pubmed/16621965","//doi.org/10.1182/blood-2007-08-106153","//www.ncbi.nlm.nih.gov/pubmed/18268093","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3014031","//doi.org/10.1681/ASN.2010030315","//www.ncbi.nlm.nih.gov/pubmed/21051740","//doi.org/10.1038/nrneph.2010.155","//www.ncbi.nlm.nih.gov/pubmed/21102542","//doi.org/10.1007/s00467-008-0964-1","//www.ncbi.nlm.nih.gov/pubmed/18800230","//doi.org/10.1681/ASN.2006080811","//www.ncbi.nlm.nih.gov/pubmed/17599974","//doi.org/10.1093/ndt/gfq160","//www.ncbi.nlm.nih.gov/pubmed/20305136","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1717216","//doi.org/10.1136/adc.76.6.518","//www.ncbi.nlm.nih.gov/pubmed/9245850","//doi.org/10.1681/ASN.2004100861","//www.ncbi.nlm.nih.gov/pubmed/15728781","//doi.org/10.1056/NEJMra0902814","//www.ncbi.nlm.nih.gov/pubmed/19846853","//doi.org/10.1097/MNH.0b013e3283378f25","//www.ncbi.nlm.nih.gov/pubmed/20186056","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2723971","//doi.org/10.2215/CJN.01090209","//doi.org/10.1097/MNH.0b013e32833aff4a","//www.ncbi.nlm.nih.gov/pubmed/20539230","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3159000","//doi.org/10.1007/s12185-009-0476-1","//www.ncbi.nlm.nih.gov/pubmed/20058209","//doi.org/10.1182/blood-2010-07-271445","//www.ncbi.nlm.nih.gov/pubmed/20686117","//doi.org/10.1053/j.seminhematol.2003.10.003","//www.ncbi.nlm.nih.gov/pubmed/14727254","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2200836","//doi.org/10.1182/blood-2007-04-084533","//www.ncbi.nlm.nih.gov/pubmed/17914026","//doi.org/10.1055/s-0030-1262881","//www.ncbi.nlm.nih.gov/pubmed/20865636","//doi.org/10.1002/jca.20240","//www.ncbi.nlm.nih.gov/pubmed/20568098","//doi.org/10.1111/j.1537-2995.2007.01405.x","//www.ncbi.nlm.nih.gov/pubmed/17880609","//doi.org/10.1182/blood-2009-03-205096","//www.ncbi.nlm.nih.gov/pubmed/19704120","//doi.org/10.1007/s40265-013-0147-7","//www.ncbi.nlm.nih.gov/pubmed/24249647","http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm272990.htm","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2829836","//doi.org/10.1053/j.ajkd.2009.10.009","//doi.org/10.1111/j.1525-139X.2007.00379.x","//www.ncbi.nlm.nih.gov/pubmed/18251954","//doi.org/10.1055/s-0030-1262887","//www.ncbi.nlm.nih.gov/pubmed/20865642","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3109948","//doi.org/10.2215/CJN.10181110","//www.ncbi.nlm.nih.gov/pubmed/21617085","//doi.org/10.2215/CJN.00050505","//www.ncbi.nlm.nih.gov/pubmed/17699195","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3163808","//doi.org/10.1007/s00467-011-1929-3","//www.ncbi.nlm.nih.gov/pubmed/21643943","//doi.org/10.1055/s-2006-939767","//www.ncbi.nlm.nih.gov/pubmed/16575686","http://rdcu.be/mPZG","//doi.org/10.1186/s13023-016-0537-5","https://www.wikidata.org/wiki/Q17165460?uselang=%E2%A7%BClang%E2%A7%BD#P1995","http://apps.who.int/classifications/icd10/browse/2016/en#/D59.3","http://www.icd9data.com/getICD9Code.ashx?icd9=283.11","http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=2134"],"sections":[{"toclevel":1,"level":"2","line":"Signs and symptoms","number":"1","index":"1","fromtitle":"Atypical_hemolytic_uremic_syndrome","byteoffset":2040,"anchor":"Signs_and_symptoms"},{"toclevel":2,"level":"3","line":"Comorbidities","number":"1.1","index":"2","fromtitle":"Atypical_hemolytic_uremic_syndrome","byteoffset":8858,"anchor":"Comorbidities"},{"toclevel":1,"level":"2","line":"Mechanisms","number":"2","index":"3","fromtitle":"Atypical_hemolytic_uremic_syndrome","byteoffset":10063,"anchor":"Mechanisms"},{"toclevel":1,"level":"2","line":"Diagnosis","number":"3","index":"4","fromtitle":"Atypical_hemolytic_uremic_syndrome","byteoffset":11287,"anchor":"Diagnosis"},{"toclevel":1,"level":"2","line":"Treatment","number":"4","index":"5","fromtitle":"Atypical_hemolytic_uremic_syndrome","byteoffset":14913,"anchor":"Treatment"},{"toclevel":2,"level":"3","line":"Plasma exchange/infusion","number":"4.1","index":"6","fromtitle":"Atypical_hemolytic_uremic_syndrome","byteoffset":16516,"anchor":"Plasma_exchange/infusion"},{"toclevel":2,"level":"3","line":"Eculizumab","number":"4.2","index":"7","fromtitle":"Atypical_hemolytic_uremic_syndrome","byteoffset":18238,"anchor":"Eculizumab"},{"toclevel":2,"level":"3","line":"Dialysis","number":"4.3","index":"8","fromtitle":"Atypical_hemolytic_uremic_syndrome","byteoffset":19116,"anchor":"Dialysis"},{"toclevel":2,"level":"3","line":"Kidney transplantation","number":"4.4","index":"9","fromtitle":"Atypical_hemolytic_uremic_syndrome","byteoffset":20627,"anchor":"Kidney_transplantation"},{"toclevel":1,"level":"2","line":"Prognosis","number":"5","index":"10","fromtitle":"Atypical_hemolytic_uremic_syndrome","byteoffset":22686,"anchor":"Prognosis"},{"toclevel":1,"level":"2","line":"Epidemiology","number":"6","index":"11","fromtitle":"Atypical_hemolytic_uremic_syndrome","byteoffset":25282,"anchor":"Epidemiology"},{"toclevel":1,"level":"2","line":"Society and culture","number":"7","index":"12","fromtitle":"Atypical_hemolytic_uremic_syndrome","byteoffset":26357,"anchor":"Society_and_culture"},{"toclevel":2,"level":"3","line":"Naming","number":"7.1","index":"13","fromtitle":"Atypical_hemolytic_uremic_syndrome","byteoffset":26381,"anchor":"Naming"},{"toclevel":2,"level":"3","line":"Research directions","number":"7.2","index":"14","fromtitle":"Atypical_hemolytic_uremic_syndrome","byteoffset":26575,"anchor":"Research_directions"},{"toclevel":1,"level":"2","line":"References","number":"8","index":"15","fromtitle":"Atypical_hemolytic_uremic_syndrome","byteoffset":27005,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"9","index":"16","fromtitle":"Atypical_hemolytic_uremic_syndrome","byteoffset":30981,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Atypical hemolytic uremic syndrome","iwlinks":[{"prefix":"d","url":"https://www.wikidata.org/wiki/Q17165460","*":"d:Q17165460"}],"properties":[{"name":"wikibase_item","*":"Q17165460"}]}}